Franseen Needle Research Articles

Clinical Impact of EUS-Guided Fine Needle Biopsy Using a Novel Franseen Needle for Histological Assessment of Pancreatic Diseases.

Background and Aims Several studies have shown the benefits of endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) using a Franseen needle for histological assessment. However, studies focusing on pancreatic diseases are limited and the safety of this method has not been well assessed. We aimed to assess the current status and issues of EUS-FNB in the diagnosis of pancreatic diseases. Materials and Methods We retrospectively reviewed 87 consecutive EUS-FNB specimens using either a 22-gauge Franseen needle (Group A, N = 51) or a conventional 22-gauge fine-needle aspiration needle (Group B, N = 36) for pancreatic diseases, and the diagnostic accuracy and safety were compared. Final diagnoses were obtained based on surgical pathology or a minimum six-month clinical follow-up. Results Although the diagnostic accuracy for malignancy was 96.1% in Group A versus 88.9% in Group B, with no statistically significant difference (P = 0.19), the median sample area was significantly larger in Group A (4.07 versus 1.31mm2, P < 0.0001). There were no differences between the two needles in the locations from which the specimens were obtained. Adverse events occurred in one case (2%) in Group A (mild pancreatitis) and none in Group B with no statistical significance (P = 0.586). Although there was no case of bleeding defined as adverse events, 2 cases in Group A showed active bleeding during the procedure with increase in the echo-free space, which required CT scanning to rule out extravasation. Eventually, the bleeding stopped spontaneously. Conclusions Given its guaranteed ability to obtain core specimens and comparable safety, and although the risk of bleeding should be kept in mind, EUS-FNB using a Franseen needle is likely to become a standard procedure for obtaining pancreatic tissue in the near future.

Prospective comparison study of franseen needle and standard needle use for pancreatic lesions under EUS guidance.

Background and Objectives:A needle with Franseen geometry for fine needle aspiration is now available. However, no reports have described prospective evaluations of the Franseen needle or comparisons with the standard needle. The aim of this comparative prospective study was to evaluate the histological diagnostic yield of the Franseen needle and the standard needle using tissue obtained by a single pass of each for the same lesion.Patients and Methods:In this study, only tissue obtained by the first pass using the Franseen needle was used. As a comparison group, only tissue obtained from the same lesion by a second pass using the standard needle was used. Evaluation of the histological diagnostic yield of the needles was based on tissue obtained by each single pass with no additional passes.Results:A total of 56 patients were prospectively enrolled. The rate of adequate tissue obtained was significantly higher for the Franseen needle than for the standard needle (89.4% vs. 62.5%, respectively; P < 0.05). The sensitivity and accuracy of the Franseen needle were 80.7%, and 84.6%, respectively, while those for the standard needle were 59.6% and 63.5%, respectively.Conclusions:The Franseen needle offers a better rate of obtaining adequate tissue and higher diagnostic accuracy than the standard needle.

Prospective, multicenter, observational study of tissue acquisition through EUS-guided fine-needle biopsy using a 25G Franseen needle.

Background:Recently, EUS-guided fine-needle biopsy (EUS-FNB) using a Franseen needle was developed for histological tissue acquisition. However, the yield of a 25G Franseen needle when acquiring histological core tissue has been unclear.Patients and Methods:We performed a prospective, multicenter, and observational cohort study that included 100 solid lesions scheduled for EUS-FNB using a 25G Franseen needle at eight centers in Hokkaido, Japan. Only EUS-FNB specimens acquired at the first pass were evaluated without a rapid on-site evaluation. The tissue acquisition rate, acquisition rate of an adequate specimen for histological assessment, the quality of tissue sample, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), diagnostic accuracy, and adverse events were evaluated.Results:We analyzed a total of 100 solid lesions in 100 patients. The patients were 57 males and 43 females with a median age of 70 years. The technical success rate was 100%. The tissue acquisition rate was 95.0%. The acquisition rate of an adequate specimen for histological assessment was 82.0%. The sensitivity, specificity, PPV, NPV, and diagnostic accuracy were 87.0%, 100%, 100%, 40.0%, and 88.0%, respectively. The adverse event rate was 1.0%, and it was reported in only one patient who had a moderate pancreatic fistula.Conclusions:EUS-FNB using the 25G Franseen needle was feasible, and adequate histological core tissue samples were acquired with this method.

A Multi-Center Retrospective Study of 420 EUS-Guided Fine Needle Core Liver Biopsy with a Modified 1-Pass 1-Actuation Wet Suction Technique Comparing Two Types of EUS Core Needles

Introduction: Endoscopic Ultrasound guided (EUS) Fine Needle Core Biopsy (FNCB) has proven to be safe and effective technique for diagnosis and staging of liver parenchymal disease. We evaluated the diagnostic yield, specimen adequacy in EUS-guided parenchymal biopsies and documented adverse events. We compared two types of EUS 19 G core needles. Methods: This is a multi-center, retrospective study of 420 patients with unexplained abnormal liver function tests who were referred for EUS evaluation of elevated liver enzymes to evaluate for biliary obstruction and pancreatic pathology. EUS-guided liver biopsy (EUS-LB) was performed at the same session after biliary obstruction was excluded. We compared EUS-LB in 210 patients using a Franseen needle to 210 patients using a Fork-tip needle, using a modified 1-pass 1-actuation wet suction technique in patients referred for abnormal liver function tests. We compared intact specimen length (ISL), total specimen length (TSL), complete portal triads (CPT) and adverse events (AE). Comparison between means used a 2-sample Z test and Levene's test found equal variance between all compared means except for mean TSL of patients with a fibrosis score of 0-2. Results: 420 consecutive patients underwent EUS-LB and data were retrospectively evaluated. Median patient age was 52 yrs(range 7-84) and 185(44%) were male. The fork tip needle had an average ISL of 2.7 cm, TSL of 6 cm, and mean 19.5 CPT(range 7-73). Abdominal pain occurred in 35 patients(17%) immediately post-procedure, which resolved in all patients except two after intravenous administration of a low-dose narcotic. Subcapsular hematomas occurred in 1(0.5%) patients. The Franseen needle had an average ISL of 3.1 cm, TSL of 6.5 cm, and mean of 24 CPT(range 8-49). Abdominal pain occurred in 4 patients(2%) immediately post-procedure, which resolved in all patients after intravenous administration of a low-dose narcotic. Subcapsular hematoma occurred in 1(0.5%) and bile leak in 1(0.4%) patients. Conclusion: This is a multi-center comparative study of 2 19G second generation EUS needles of different designs, in patient undergoing EUS-LB. The average CPT and ISL were significantly higher in the Franseen needle compared to fork-tip needle. Both needles using a modified 1-pass 1-actuation wet suction technique met 100% AASLD specimen adequacy (>11 CPT or TSL >2.5cm). AE were comparable between both needles.752_A Figure 1. Gross Specimen752_B Figure 2. Comparison between needle type based on fibrosis score752_C Figure 3. Comparison between Franseen and Fork-tip needles

Diagnostic ability of a 22G Franseen needle in endoscopic ultrasound-guided fine needle aspiration of subepithelial lesions.

The differential diagnosis of gastrointestinal subepithelial lesions (SELs) such as gastrointestinal stromal tumors from other benign tumors is important. In the present study, adequate sample rates of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) with a 22G Franseen needle for SELs were evaluated. The present study included 57 consecutive lesions (61 sessions) of EUS-FNA using a 22G needle to evaluate SELs between July 2013 and October 2017. Adequate sample rates were compared retrospectively between a 22G conventional needle group (C group) and a 22G Franseen needle group (F group). The overall adequate sample rate was 80.3%. The adequate sample rates in the C and F groups were 75.0% (33/44) and 94.1% (16/17), respectively (P=0.15). For lesions ≥20 mm, the adequate sample rates were 82.8% (24/29) in the C group and 91.7% (11/12) in the F group, 8.9% higher in the F group. However, for lesions <20 mm, the adequate sample rates were 60% (9/15) in the C group and 100% (5/5) in the F group, 40% higher in the F group (P=0.65, 0.26). In conclusion, the results of the present study suggested that using a 22G Franseen needle for EUS-FNA evaluation of SELs may improve adequate sample rates in small lesions <20 mm in diameter.

Mo1321 PROSPECTIVE COMPARISON STUDY OF FRANSEEN NEEDLE AND STANDARD NEEDLE USE FOR PANCREATIC LESIONS UNDER EUS-GUIDANCE

To ensure diagnosis with EUS-FNA, various efforts have been reported, such as on-site evaluation and technical methods including slow pull and wet suction technique. On the other hand, obtaining sufficient tissue is one of the most important points to facilitate the assessment and subtyping of various neoplasms and for further immunohistochemical investigations of tumor type. In addition, if treatment such as chemotherapy according to the genotype of tumors improves, sufficient tissue may be needed to treat patients using an individualized approach according to the histological results. Recently, an FNA needle with Franseen geometry has become available. However, there are no reports of prospective evaluations of the Franseen needle and of comparison studies with the standard needle. The aim of this comparative prospective study was to evaluate the histological diagnostic yield of the Franseen needle and the standard needle using tissue obtained by a single pass of each for same lesion. Only tissue obtained by the first pass using the Franseen needle (22G) was used. As a comparison group, only tissue obtained by the second pass using the standard needle (22G) was used for same lesion. Evaluation of histological diagnostic yield was based on tissue obtained by each single pass with no additional passes. A total of 56 patients (median age, 72.5 years; age range, 58-84 years; 30 men, 26 women) were prospectively enrolled. EUS-FNA was successfully performed using first the Franseen needle and then the standard needle (technical success 100%). The median size of the target lesions was 20 mm. The location of the puncture site was the head (n=27), body (n=19), and tail (n=10) of the pancreas. The final diagnosis was: malignant disease n=52 (92.9%), including adenocarcinoma n=47, metastatic tumor n=2, neuroendocrine carcinoma n=1, and malignant lymphoma n=2; and benign disease n=4 (7.1), including chronic pancreatitis n=1, autoimmune pancreatitis n=2, and neuroendocrine tumor n=1. Among benign diseases, the final diagnosis was based on clinical follow-up without progressive disease and surgical resection (neuroendocrine tumor n=1). The rate of adequate tissue obtained by the Franseen needle was 89.3%. On the other hand, the rate of adequate tissue obtained by the standard needle was 62.5%. Thus, the rate of adequate tissue was significantly higher for the Franseen needle than for the standard needle (P<0.05). The sensitivity and accuracy of the Franseen needle were 80.7%, and 84.6%, respectively. On the other hand, thats of the standard needle were 59.6%, and 63.5%, respectively. Compared with the standard needle, the diagnostic yield and rate of adequate tissue with the Franseen needle were good. The Franseen needle has a better rate of obtaining adequate tissue and a higher diagnostic accuracy than the standard needle.

Su1438 DIAGNOSTIC ABILITY OF EUS-FNA FOR GASTROINTESTINAL SUBMUCOSAL TUMOR

With gastrointestinal submucosal tumor (SMT), differentiating gastrointestinal stromal tumor (GIST) and malignant lymphoma from other benign tumors is clinically important. Distinguishing between pathologies based on imaging alone is difficult, and endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is useful. However, adequate specimen rate and the diagnostic ability with EUS-FNA are slightly lower for SMT than for pancreatic mass lesions and lymph nodes. To improve the adequate specimen rate and correct diagnosis rate of EUS-FNA for SMT, we examined correlations with lesion site, tumor diameter and puncture needle. We retrospectively analyzed 78 consecutive cases (79 lesions: esophagus, n=7; stomach, n=69; duodenum, n=1; rectal, n=2) with SMTs who had undergone EUS-FNA at our hospital between July 2013 and October 2017. The overall adequate specimen rate by EUS-FNA was 82.3%. Adequate samples were obtained for 100% of esophageal lesions, 81.2% of stomach lesions, 0% of duodenal lesions, and 100% of rectal lesions. In terms of tumor diameter, adequate samples were obtained from 73.1% (19 of 26) of lesions <20 mm in diameter, and 86.8% (46 of 53) of lesions ≥20 mm in diameter. Among the 79 lesions, a definitive final diagnosis was obtained for 36 (45.6%; 30 cases were surgically resected, and 6 cases were confirmed on follow-up to be malignant lymphoma or GIST). Of the 36 cases with definitive final diagnosis, 27 were GISTs, 3 were schwannomas, 1 was malignant lymphoma, 1 was ectopic pancreas, 1 was lymph node metastasis, 1 was metastatic gastric cancer, and 2 were others. The accuracy of EUS-FNA was 83.3%, and was relatively high at 96.3% for GIST. For GIST <20 mm in diameter, 3 of 5 cases showed a homogenous hypoechoic pattern on EUS, and differentiation from imaging alone was difficult. When examined by puncture needle separately, the adequate specimen rate with a conventional-type 22-G needle was 72.7% (40 of 55) in total and 60% (12 of 20) in lesions <20 mm in diameter, whereas use of a 22-G Franseen needle yielded adequate specimen rates of 88.9% (16 of 18) overall and 83.3% (5 of 6) in lesions <20 mm in diameter, representing relatively high levels (p = 0.21, 0.38). Usually, as tumor size increases, the postoperative metastatic rate increases in GIST. Heterogeneous internal echogenicity, ulceration, cystic changes, and presence of highly echoic spots are known as useful for diagnosing GIST, but distinguish between GIST and other diseases based on imaging alone was difficult in this study. Immunohistochemical diagnosis by EUS-FNA is necessary even for small lesions, and improvements in the adequate specimen rate are required. In EUS-FNA for SMT, a 22-G Franseen needle may be the first choice, but further accumulation of cases is necessary in the future.

A retrospective histological comparison of EUS-guided fine-needle biopsy using a novel franseen needle and a conventional end-cut type needle.

Background and Objectives:Recently, a 22G Franseen needle for EUS-guided fine-needle biopsy (EUS-FNB) with three novel symmetric heels has been developed to adequately obtain a core tissue.Methods:All 38 consecutive patients with pancreatic masses who underwent EUS-FNB using a Franseen needle were investigated retrospectively to assess the efficacy and safety of EUS-FNB using the Franseen needle. Then, the EUS-FNB outcomes and histological assessments of the tissue obtained by EUS-FNB using the Franseen needle and EUS-FNA using the conventional end-cut type needle for each of the 30 pancreatic ductal adenocarcinoma cases were compared.Results:An accurate histological diagnosis of the Franseen needle was achieved with a mean of 2 passes in 97.4% of patients. Although the accurate histological diagnosis rate of pancreatic ductal adenocarcinoma was not significantly different (96.7% vs. 93.3%, P = 0.55), the mean number of passes in the Franseen needle was significantly less than that in the conventional needle (2.1 ± 0.4 vs. 3.2 ± 0.8, P < 0.001). The presence of desmoplastic fibrosis with neoplastic cellular elements and venous invasion were significantly higher (96.7% vs. 40.0%, P < 0.001 and 23.3% vs. 0%, P < 0.01, respectively) and the amount of obtained tissue was significantly larger with the Franseen needle (2.13 mm2 vs. 0.45 mm2, P < 0.001).Conclusions:EUS-FNB using the Franseen needle enables the acquisition of a larger amount of tissue sample and achieves an accurate histological diagnosis with a smaller number of passes than the conventional end-cut type needle.

Cohort study comparing the diagnostic yields of 2 different EUS fine-needle biopsy needles

Two second-generation, flexible EUS fine-needle biopsy (FNB) needles have been marketed recently in the United States. Thus far, there have been no comparative studies of the diagnostic yield of these needles. The aim of this study was to compare the diagnostic yield achieved with FNB by using 1 needle during 1 time period and the other needle during a second time period. Consecutive patients with solid lesions undergoing EUS-FNB by using 1 of two 22-gauge FNB needles (Franseen needle or fork-tip) at 2 different time intervals were included. The final diagnosis was based on positive pathology results. In cases of a negative pathology result, the final diagnosis was based on clinical and imaging follow-up. A total of 194 lesions (97 in each group) were sampled in 179 patients. Rapid on-site evaluation (ROSE) was used in 12% of cases. The overall diagnostic yield was lower in the Franseen needle group compared with the fork-tip needle group (61/97 [63%] vs 75/97 [77%], odds ratio (OR) 2.01, 1.07-3.8; P= .027). Similarly, subanalysis of the yield for solid pancreatic masses demonstrated a lower yield with the Franseen needle (34/53 [64%] vs 40/47 [85%], OR 3.4, 9.1-8.9; P= .017). Multivariate analysis controlling for the number of passes, site, and lesion size did not have any effect on diagnostic yield. There were no adverse events in either group. In this first, large, single-center comparative cohort study of 2 new, second-generation EUS-FNB needles of different design, the diagnostic yield when used primarily without ROSE was high in both groups but was significantly higher when a fork-tip needle was used.

Endoscopic ultrasonography-guided biopsy using a Franseen needle design: Initial assessment.

Recently, a 22-gauge (G) needle with a Franseen tip design was developed for endoscopic ultrasonography-guided fine-needle biopsy (EUS-FNB). The present study evaluated the performance of the Franseen biopsy needle in EUS-guided tissue acquisition. This is a retrospective study of patients who underwent EUS-FNB using the Franseen needle. Lesions were sampled using either the Franseen needle only or after failed diagnostic fine-needle aspiration (FNA). After rapid onsite evaluation (ROSE), two dedicated passes were carried out for histological assessment using the cell block technique. Main outcomes were: (i) rates of diagnostic adequacy for ROSE and histological diagnosis; and (ii) quality of histology as determined by total tissue area and tumor percentage in tissue. Thirty patients underwent EUS-FNB of pancreatic or other masses over a 3-month period. Twenty-four lesions were sampled using the Franseen needle only and six after failed diagnostic FNA. Final diagnosis was pancreatic cancer in 12, gastrointestinal stromal cell tumor in five, other tumors in four and benign disease in nine. Diagnostic adequacy for ROSE was 96.6% and histological diagnosis was established in 96.7% of patients. Median tissue area was 2.9 mm2 (IQR = 0.68-8.71 mm2 ) and median tumor percentage in tissue was 73.9% (IQR = 44-97.6). Rates of technical success and adverse events were 96.7 and 3.3%, respectively. Preliminary data suggest that the Franseen needle yields diagnostic material for ROSE and histology in >95% of patients.

“Parapharyngeal space” tumors: A cytopathological study of 24 cases on fine‐needle aspiration

The parapharyngeal space (PPS) is a well-defined anatomic zone of loose connective tissue lying deep to the tonsil and lateral to the pharynx. Neoplasms arising within the PPS are rare. We retrospectively reviewed 24 PPS fine-needle aspirations (FNAs) performed at The Johns Hopkins Hospital over the past 16 years (1987-2002). Patients presented with neck pain, dysphagia, and/or intraoral swelling of varying duration. Radiographic imaging disclosed PPS masses, varying in size from 2.5 to 8 cm. The most common clinicoradiographic suspicion was a nerve sheath tumor. Six cases had FNA performed using a 23-gauge needle via a transoral approach in the outpatient suite whereas the remainder were aspirated via a 22-gauge Franseen needle under CT guidance. Six of 24 cases (25%) were nondiagnostic due to lack of adequate cellular material. Of the 18 cases considered diagnostic, there were nine (50%) pleomorphic adenomas (PAs); three (17%) squamous-cell carcinomas (SCC); and one each of oncocytoma, adenocarcinoma, not otherwise specified (NOS), adenoid cystic carcinoma, lipoma, neurofibroma, and non-Hodgkin lymphoma, together comprising the remaining 33%. Four of the six cases deemed nondiagnostic (consisting predominantly of blood) on subsequent tissue follow-up revealed paraganglioma (two cases), SCC (one case), and schwannoma (one case). PPS is an uncommon target of an FNA procedure. PPS masses represent a heterogeneous group of neoplasms of which PA appears most common, representing 50% of our diagnostic cases. The rate of nondiagnostic FNA samples is moderately high due to excessive bleeding encountered in this location and other technical problems relating to adequately targeting the lesion in close vicinity of major neck vessels.

Percutaneous Transthoracic Needle Biopsy of the Lung: Review of 612 Lesions

The results and complications of 651 pulmonary fine-needle aspiration biopsies (FNABs) were reviewed. The number of needle passes and needle size were correlated to pneumothorax and chest tube placement rates. FNAB of the lung was performed on 651 occasions in 612 patients with 18- to 22-gauge Franseen needles. Diagnostic rates were calculated. The number of needle passes performed and needle size used were evaluated for their association with pneumothorax and subsequent chest tube placement. Diagnostic accuracy was 94% with sensitivity for malignancy of 95%. Positive and negative predictive values were 99.5% and 90%, respectively. Pneumothorax occurred in 26.9% of patients with 9.2% requiring chest tube placement. Increasing numbers of needle passes and larger needle sizes did not increase the rates of pneumothorax or chest tube placement. FNAB of the lung has excellent diagnostic rates and remains the procedure of choice for diagnosing pulmonary lesions. This large study contradicts perceptions that pneumothorax and chest tube placement rates decrease with thinner needles and fewer passes.

Transthoracic aspiration biopsy of pulmonary and mediastinal lesions

Thoracic aspiration biopsy (TAB) constitutes a useful technique in establishing a diagnosis in diseases of the lungs and mediastinum. Results obtained from 1046 fluoroscopically-guided TABs are presented with review of the most important aspects of the technique. Diagnostic accuracy in malignancy detection was 93.8% in lung lesions ( n = 984) and 74.5% in mediastinal lesions ( n = 62). Sensitivity was higher in peripheral than in central lesions (96% vs. 87%, respectively). Specificity was 100% in both groups. Sensitivity in lesions smaller than 2 cm was 70% and 94% in larger lesions. Aspiration biopsies performed with Chiba and Franseen needles showed a similar sensitivity (95%) higher than with other types of needles. A pneumothorax developed in 138 patients (13.2%). Only eight of these required the use of an endothoracic tube (0.8% of all biopsies).

Cavernous hemangioma of the liver: role of percutaneous biopsy.

Fifteen patients with liver masses detected with imaging were strongly considered clinically to have malignant disease. In each case, the possibility of a hepatic cavernous hemangioma was raised upon review of the images. With use of a 20-gauge Franseen needle, a percutaneous hepatic biopsy was performed in all 15 cases, and the diagnosis of cavernous hemangioma was confirmed. There were no complications from the biopsy. Twelve biopsies were performed on an outpatient basis. On the basis of the biopsy results, the care and treatment of each patient were significantly altered. When imaging data are not sufficient to determine that a liver mass is benign, even if the possibility of cavernous hemangioma is entertained, a percutaneous biopsy can be safely performed and can yield a specific histologic diagnosis.

Carcinoma of the Prostate: Use of the Franseen Needle for Perineal Prostatic Biopsy

Carcinoma of the Prostate: Use of the Franseen Needle for Perineal Prostatic Biopsy

The Role of Perineal Punch Biopsy in the Diagnosis and Treatment of Carcinoma of the Prostate

No AccessJournal of Urology1 Mar 1960The Role of Perineal Punch Biopsy in the Diagnosis and Treatment of Carcinoma of the Prostate Miles W. Thomley, James B. Jamison, and W. Ansel Derrick Miles W. ThomleyMiles W. Thomley More articles by this author , James B. JamisonJames B. Jamison More articles by this author , and W. Ansel DerrickW. Ansel Derrick More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)65709-4AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail © 1960 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited by Addonizio J and Kapoor S (1976) Perineal seeding of prostatic carcinoma after needle biopsyUrology, 10.1016/0090-4295(76)90293-4, VOL. 8, NO. 5, (513-515), Online publication date: 1-Nov-1976. Puigvert A and Vicente J (1975) Nuestra experiencia en el tratamiento combinado del carcinoma de la prostataActa Endoscopica, 10.1007/BF03025238, VOL. 5, NO. 1, (21-32), Online publication date: 1-Jan-1975. Purser B, Robinson B and Mostofi F (2018) Comparison of Needle Biopsy and Transurethral Resection Biopsy in the Diagnosis of Carcinoma of the ProstateJournal of Urology, VOL. 98, NO. 2, (224-228), Online publication date: 1-Aug-1967.Labardini M and Nesbit R (2018) Perineal Extension of Adenocarcinoma of the Prostate Gland After Punch BiopsyJournal of Urology, VOL. 97, NO. 5, (891-893), Online publication date: 1-May-1967.Denton S, Valk W, Jacobson J and Kettunen R (2018) Comparison of the Perineal Needle Biopsy and the Transurethral Prostatectomy in the Diagnosis of Prostatic Carcinoma: An Analysis of 300 CasesJournal of Urology, VOL. 97, NO. 1, (127-129), Online publication date: 1-Jan-1967.Wendel R and Evans A (2018) Complications of Punch Biopsy of the Prostate GlandJournal of Urology, VOL. 97, NO. 1, (122-126), Online publication date: 1-Jan-1967.Arduino L and Murphy F (2018) Carcinoma of the Prostate: Use of the Franseen Needle for Perineal Prostatic BiopsyJournal of Urology, VOL. 89, NO. 5, (732-736), Online publication date: 1-May-1963.Campbell J, Thomley M and Parsons R (2018) Complications of Radical Prostatic SurgeryJournal of Urology, VOL. 89, NO. 2, (253-254), Online publication date: 1-Feb-1963. Volume 83Issue 3March 1960Page: 305-307 Advertisement Copyright & Permissions© 1960 by The American Urological Association Education and Research, Inc.MetricsAuthor Information Miles W. Thomley More articles by this author James B. Jamison More articles by this author W. Ansel Derrick More articles by this author Expand All Advertisement PDF downloadLoading ...

Needle Biopsy of Prostate

No AccessJournal of Urology1 Feb 1960Needle Biopsy of Prostate Sam Peck Sam PeckSam Peck More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)65681-7AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail © 1960 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited byHastak S, Gammelgaard J and Holm H (2018) Ultrasonically Guided Transperineal Biopsy in the Diagnosis of Prostatic CarcinomaJournal of Urology, VOL. 128, NO. 1, (69-70), Online publication date: 1-Jul-1982.Kaufman J (2018) Editorial CommentJournal of Urology, VOL. 128, NO. 1, (70-71), Online publication date: 1-Jul-1982.Wendel R and Evans A (2018) Complications of Punch Biopsy of the Prostate GlandJournal of Urology, VOL. 97, NO. 1, (122-126), Online publication date: 1-Jan-1967.Labardini M and Nesbit R (2018) Perineal Extension of Adenocarcinoma of the Prostate Gland After Punch BiopsyJournal of Urology, VOL. 97, NO. 5, (891-893), Online publication date: 1-May-1967.Cooper J and Robinson B (2018) The Productivity of Prostatic Needle Biopsy in the Recognition of Early Prostatic CancerJournal of Urology, VOL. 97, NO. 5, (894-898), Online publication date: 1-May-1967.Schmidt J and Patterson M (2018) Needle Biopsy Study of Chronic ProstatitisJournal of Urology, VOL. 96, NO. 4, (519-533), Online publication date: 1-Oct-1966.Rowan R and Howley T (2018) Postoperative ImpotenceJournal of Urology, VOL. 95, NO. 1, (68-69), Online publication date: 1-Jan-1966.Burkholder G and Kaufman J (2018) Local Implantation of Carcinoma of the Prostate with Percutaneous Needle BiopsyJournal of Urology, VOL. 95, NO. 6, (801-804), Online publication date: 1-Jun-1966.Arduino L and Murphy F (2018) Carcinoma of the Prostate: Use of the Franseen Needle for Perineal Prostatic BiopsyJournal of Urology, VOL. 89, NO. 5, (732-736), Online publication date: 1-May-1963.Sika J and Lindquist H (2018) Relationship of Needle Biopsy Diagnosis of Prostate to Clinical Signs of Prostatic Cancer: An Evaluation of 300 CasesJournal of Urology, VOL. 89, NO. 5, (737-745), Online publication date: 1-May-1963.Fortunoff S (2018) Needle Biopsy of the Prostate : A Review of 346 BiopsiesJournal of Urology, VOL. 87, NO. 2, (159-163), Online publication date: 1-Feb-1962.Emmett J, Barber K and Jackman R (2018) Transrectal Biopsy to Detect Prostatic Carcinoma: A Review and Report of 203 CasesJournal of Urology, VOL. 87, NO. 3, (460-474), Online publication date: 1-Mar-1962.Veenema R (2018) Perineal Prostatic Cup Biopsy: Technique and EvaluationJournal of Urology, VOL. 87, NO. 4, (585-592), Online publication date: 1-Apr-1962. Volume 83Issue 2February 1960Page: 176-180 Advertisement Copyright & Permissions© 1960 by The American Urological Association Education and Research, Inc.MetricsAuthor Information Sam Peck More articles by this author Expand All Advertisement PDF downloadLoading ...

Sexual Potency after Perineal Biopsy

No AccessJournal of Urology1 Apr 1957Sexual Potency after Perineal Biopsy Carl P. Dahlen, and Willard E. Goodwin Carl P. DahlenCarl P. Dahlen More articles by this author , and Willard E. GoodwinWillard E. Goodwin More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)66616-3AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail © 1957 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited ByWalsh P and Donker P (2018) Impotence following radical prostatectomy: Insight into etiology and preventionJournal of Urology, VOL. 167, NO. 2 Part 2, (1005-1010), Online publication date: 1-Feb-2002.Walsh P and Donker P (2018) Impotence Following Radical Prostatectomy: Insight Into Etiology and PreventionJournal of Urology, VOL. 128, NO. 3, (492-497), Online publication date: 1-Sep-1982.Boxer R, Kaufman J and Goodwin W (2018) Radical Prostatectomy for Carcinoma of the Prostate: 1951–1976. A Review of 329 PatientsJournal of Urology, VOL. 117, NO. 2, (208-213), Online publication date: 1-Feb-1977.Rowan R and Howley T (2018) Postoperative ImpotenceJournal of Urology, VOL. 95, NO. 1, (68-69), Online publication date: 1-Jan-1966.Melicow M (2018) Cancer of the Prostate: Concepts and Guide Lines in Histological DiagnosisJournal of Urology, VOL. 95, NO. 6, (791-800), Online publication date: 1-Jun-1966.Becker L and Harrin W (2018) Prostatic Abscess: A Diagnostic and Therapeutic ApproachJournal of Urology, VOL. 91, NO. 5, (582-585), Online publication date: 1-May-1964.Chambers H and Balfour J (2018) The Incidence of Impotence Following Pelvic Fracture with Associated Urinary Tract InjuryJournal of Urology, VOL. 89, NO. 5, (702-703), Online publication date: 1-May-1963.Arduino L and Murphy F (2018) Carcinoma of the Prostate: Use of the Franseen Needle for Perineal Prostatic BiopsyJournal of Urology, VOL. 89, NO. 5, (732-736), Online publication date: 1-May-1963.Ellis W and Grayhack J (2018) Sexual Function in Aging Males after Orchiectomy and Estrogen TherapyJournal of Urology, VOL. 89, NO. 6, (895-899), Online publication date: 1-Jun-1963.Fortunoff S (2018) Needle Biopsy of the Prostate : A Review of 346 BiopsiesJournal of Urology, VOL. 87, NO. 2, (159-163), Online publication date: 1-Feb-1962.Finkle A and Moyers T (2018) Sexual Potency in Aging Males: IV. Status of Private Patients Before and After ProstatectomyJournal of Urology, VOL. 84, NO. 1, (152-157), Online publication date: 1-Jul-1960.Finkle A and Moyers T (2018) Sexual Potency in Aging Males V. Coital Ability Following Open Perineal Prostatic BiopsyJournal of Urology, VOL. 84, NO. 5, (649-653), Online publication date: 1-Nov-1960. Volume 77Issue 4April 1957Page: 660-669 Advertisement Copyright & Permissions© 1957 by The American Urological Association Education and Research, Inc.MetricsAuthor Information Carl P. Dahlen More articles by this author Willard E. Goodwin More articles by this author Expand All Advertisement PDF DownloadLoading ...